Colon Cancer Drugs Market Research Reports

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market - Product Thumbnail Image

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • Report
  • 152 Pages
From
Colorectal Cancer (CRC) Drugs/ Therapeutic Market Size, Share & Trends Analysis Report by Drug Class (Chemotherapy, Immunotherapy), By Country (U.S., U.K., Germany, Spain, Italy, France, Japan), And Segment Forecasts, 2016 - 2022 - Product Thumbnail Image

Colorectal Cancer (CRC) Drugs/ Therapeutic Market Size, Share & Trends Analysis Report by Drug Class (Chemotherapy, Immunotherapy), By Country (U.S., U.K., Germany, Spain, Italy, France, Japan), And Segment Forecasts, 2016 - 2022

  • Report
  • 99 Pages
From
Colorectal Cancer Forecast and Market Analysis to 2036 - Product Thumbnail Image

Colorectal Cancer Forecast and Market Analysis to 2036

  • Report
  • 650 Pages
From
Drug analysis: Erbitux - Product Thumbnail Image

Drug analysis: Erbitux

  • Drug Pipelines
  • 34 Pages
From
Drug analysis: Vectibix - Product Thumbnail Image

Drug analysis: Vectibix

  • Drug Pipelines
  • 23 Pages
From
Drug analysis: Cyramza - Product Thumbnail Image

Drug analysis: Cyramza

  • Drug Pipelines
  • 56 Pages
From
Drug analysis: Stivarga - Product Thumbnail Image

Drug analysis: Stivarga

  • Drug Pipelines
  • 28 Pages
From
Drug Analysis: Betaseron - Product Thumbnail Image

Drug Analysis: Betaseron

  • Drug Pipelines
  • 15 Pages
From
Drug analysis: Lonsurf - Product Thumbnail Image

Drug analysis: Lonsurf

  • Drug Pipelines
  • 18 Pages
From
Drug analysis: Avastin - Product Thumbnail Image

Drug analysis: Avastin

  • Drug Pipelines
  • 116 Pages
From
Colorectal Cancer Forecast in 18 Major Markets 2017-2027 - Product Thumbnail Image

Colorectal Cancer Forecast in 18 Major Markets 2017-2027

  • Report
  • 90 Pages
From
Colorectal Cancer - Heat Map and Analysis - Product Thumbnail Image

Colorectal Cancer - Heat Map and Analysis

  • Drug Pipelines
  • 21 Pages
From
CAS 61825-94-3 Oxaliplatin Chemical World Report - Product Thumbnail Image

CAS 61825-94-3 Oxaliplatin Chemical World Report

  • Report
  • 2024 Pages
CAS 63121-00-6 Oxaliplatin Chemical World Report - Product Thumbnail Image

CAS 63121-00-6 Oxaliplatin Chemical World Report

  • Report
  • 2160 Pages
Global Colorectal Cancer Partnering 2012 to 2018 - Product Thumbnail Image

Global Colorectal Cancer Partnering 2012 to 2018

  • Report
  • 150 Pages
From
CAS 7444-29-3 Anhydro leucovorin Chemical World Report - Product Thumbnail Image

CAS 7444-29-3 Anhydro leucovorin Chemical World Report

  • Report
  • 2087 Pages
CAS 7413-34-5 Sodium methotrexate Chemical World Report - Product Thumbnail Image

CAS 7413-34-5 Sodium methotrexate Chemical World Report

  • Report
  • 2006 Pages
CAS 5-Fluorouracil World Consumption Report - Product Thumbnail Image

CAS 5-Fluorouracil World Consumption Report

  • Report
  • 2079 Pages
CAS Methotrexate World Consumption Report - Product Thumbnail Image

CAS Methotrexate World Consumption Report

  • Report
  • 2095 Pages
CAS 1480-96-2 2-Methoxy-5-fluorouracil Chemical World Report - Product Thumbnail Image

CAS 1480-96-2 2-Methoxy-5-fluorouracil Chemical World Report

  • Report
  • 2173 Pages
Loading Indicator

Colon (or colorectal/bowel cancer) is diagnosed in over 1 million people annually, and accounts for over 0.5 million deaths each year. According to a recent article in the renowned Lancet medical journal, in Europe the 5-year survival for colorectal cancer is less than 60% so there is certainly considerable market potential for effective and accessible new pharmaceutical drugs. Reports in the Colon Cancer Section will help industry operators, and those considering entering this market, to answer the key questions such as what are the latest clinical trials, what are the R&D trends, what is the potential for personalized medicine, where are the opportunities in major markets such as China and the US, etc. Show Less Read more

adroll